Amgen Forecasts ‘High Teens’ Growth For Biosimilars

Chairman And CEO Bradway Outlines Expectations For Amgen’s Biosimilars Business

 
• By Dave Wallace
  
Amgen logo next to syringe
Amgen chairman and CEO Bob Bradway spoke about biosimilars at the J.P. Morgan Healthcare Conference in San Francisco • Source: Shutterstock

More from Biosimilars

More from Products